OncoTherapy Science, Inc. has entered into a license agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A. (SEPPIC) to grant the exclusive rights to manufacture and sell the compact automatic emulsion-preparing devices originally developed by OncoTherapy. Under the terms of the agreement: OncoTherapy grants SEPPIC the exclusive rights to manufacture and sell the compact automatic emulsion-preparing devices; OncoTherapy will provide necessary information for such manufacture and sale to SEPPIC, and cooperate with SEPPIC; and OncoTherapy will receive royalty based on the sales amount of such devices in consideration of the licenses under this agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16 JPY | 0.00% | -5.88% | -30.43% |
04-29 | Poland's Tusk calls prosecutor over potential Orlen scandal | RE |
04-22 | OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-30.43% | 22.26M | |
+7.43% | 111B | |
+11.27% | 106B | |
-12.70% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.70% | 16.81B | |
+37.48% | 12.54B | |
-23.94% | 8.09B |
- Stock Market
- Equities
- 4564 Stock
- News OncoTherapy Science, Inc.
- OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A